Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Thalidomide × Clear all

NCT00038246 2018-10-31

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Phase 1/2 Completed

Prostatic Neoplasms